To appear in Best of the Brokers, email your research to email@example.com
ANALYSTS at Numis have raised their target price for Cambian by three per cent to 380p per share and reiterated “buy” following the health service provider’s acquisition last week of By the Bridge, fostering business that cares for children with high needs. Numis said By the Bridge has grown strongly over the years and the deal fits with Cambian’s strategy of expanding its fostering business.
PEEL Hunt said it expects Booker to report better-than-expected fourth-quarter results on Thursday and has reiterated its “buy” recommendation for the wholesaler, with a target price of 180p. The broker said the government’s ban in April on retailer’s displaying tobacco products is likely to negatively impact Booker’s sales but have a minimal impact on profits given the low gross margin on tobacco.